相关实验视频
Updated: Jan 17, 2026
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
37.4K
解读hesperidin的神经保护潜力:对阿尔茨海默氏症疾病的洞察
Payal Chauhan1, Nasir Vadia2, Suhas Ballal3
1Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.
Neuroscience
|September 22, 2025
概括
赫斯佩里丁是一种植物类黄胺,通过减少炎症和氧化应激,显示神经保护作用. 它通过准关键的病理机制来治疗阿尔茨海默病具有前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 赫斯佩里丁是一种广泛可用的饮食类黄类化合物,具有已知的药理学益处.
- 新出现的证据表明hesperidin具有显著的神经保护能力.
研究的目的:
- 审查关于西在阿尔茨海默病中的作用的当前文献.
- 探索hesperidin在神经退行性疾病的临床应用中的治疗潜力.
主要方法:
- 审查研究hesperidin的神经药理学的细胞和动物模型.
- 对支持hesperidin神经保护功能的临床证据的分析.
主要成果:
- 赫斯佩里丁可以减轻神经炎症,细胞亡和氧化应激.
- 它抑制了粉样β斑块的形成和乙胆化酶的活性.
- 赫斯佩里丁可以增强神经发生和突触可塑性.
结论:
- 赫斯佩里丁显示出与阿尔茨海默病相关的多方面的神经保护机制.
- 它的特性表明其在治疗神经退行性疾病中的临床使用潜力显著.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.5K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.7K
相关概念视频
01:22Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K